17+ hour, 21+ min ago  (250+ words) | Apex Onco - Clinical Trials news and analysis'Oncology Pipeline "The team is super responsive to my inquiries and suggestions" US public biotech company Janux drops its second project Janux has been quiet for a while now on its second project, JANX008, and…...

1+ day, 19+ hour ago  (236+ words) | Apex Onco - Clinical Trials news and analysis'Oncology Pipeline "Oncology Pipeline is my favorite CI tool" Head of Market Insights Oncology Europe Anaptys Bio's Jemperli complaint has legs GSK's pre-emptive strike against its partner Anaptys Bio " alleging material breach of a…...

1+ day, 13+ hour ago  (726+ words) Oncology Pipeline is my favorite CI tool" Head of Market Insights Oncology Europe The Companion-002 trial of tovecimig fails to show an overall survival benefit versus chemo. Compass Therapeutics still hopes for full FDA approval of its DLL4 x VEGF-targeting antibody…...

4+ day, 21+ hour ago  (587+ words) Top quality, fast and so easy to use" Director New Product Planning Oncology Pipeline is my favorite CI tool" Head of Market Insights Oncology Europe An anti-ER Riptac" enters phase 1. Four months after Johnson & Johnson spent $3bn to acquire the private…...

5+ day, 15+ hour ago  (532+ words) Top quality, fast and so easy to use" Director New Product Planning Head of Market Insights Oncology Europe Several high-profile clinical trials are set to come under the spotlight in late-breaking presentations at the ASCO conference, after being toplined as…...

5+ day, 16+ hour ago  (318+ words) Head of Market Insights Oncology Europe "The team is super responsive to my inquiries and suggestions" US public biotech company The company has started a pivotal trial of its KRAS G12 D inhibitor in pancreatic cancer." Despite ongoing setbacks in the…...

6+ day, 18+ hour ago  (368+ words) The team is super responsive to my inquiries and suggestions" US public biotech company Top quality, fast and so easy to use" Director New Product Planning The IDO/PD-L1 project m RNA-4359 shows early hints in first-line melanoma. Moderna's IDO…...

1+ week, 1+ day ago  (473+ words) Oncology Pipeline is my favorite CI tool" Head of Market Insights Oncology Europe The company's conjugate QLS5132 has produced intriguing, but early results. Several Claudin6 projects have fallen short of expectations, but Qilu is the latest to take aim at this target…...

1+ week, 1+ day ago  (441+ words) Head of Market Insights Oncology Europe "The insights provided by the analysts are great" Director New Product Planning Amgen and Gilead deliver lacklustre early clinical results with AMG 355 and denikitug respectively. Since companies started the first clinical trials with anti…...

2+ week, 16+ hour ago  (659+ words) Top quality, fast and so easy to use" Director New Product Planning The team is super responsive to my inquiries and suggestions" US public biotech company Lilly buys the dual-payload ADC specialist before it's dosed a single patient. Barely 18 months…...